Skip to content

    ADC Therapeutics SA (ADCT) stock price & financials

    View ADCT earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance64.6% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $18.46M
    $16.91M
    $23.03M
    $18.84M
    $16.43M
    -11.0%
    $23.06M
    +36.4%
    $20.85M
    -9.5%
    $19.25M
    +2.2%
    Strengthening
    Operating Profit
    -$35.56M
    -$32.44M
    -$28.46M
    -$44.15M
    -$30.97M
    +12.9%
    -$17.92M
    +44.8%
    -$25.25M
    +11.3%
    -$25.41M
    +42.4%
    Strengthening
    Net Profit
    -$43.97M
    -$30.73M
    -$38.60M
    -$56.65M
    -$40.97M
    +6.8%
    -$6.41M
    +79.1%
    -$32.97M
    +14.6%
    -$16.57M
    +70.8%
    Strengthening
    EPS
    $-0.42
    $-0.36
    $-0.50
    $-0.30
    +28.6%
    $-0.21
    +41.7%
    $-0.11
    +78.0%
    Strengthening
    Other Income
    -$8.05M
    $1.39M
    -$9.97M
    -$11.24M
    -$10.00M
    -24.1%
    $11.11M
    +700.1%
    -$7.72M
    +22.6%
    $8.85M
    Strengthening
    Interest
    $13.12M
    $11.92M
    $12.23M
    $13.00M
    $13.39M
    +2.1%
    $13.01M
    +9.2%
    $12.35M
    +1.0%
    $13.51M
    +3.9%
    Strengthening
    Depreciation
    Profit before Tax
    -$43.62M
    -$31.05M
    -$38.44M
    -$55.39M
    -$40.97M
    +6.1%
    -$6.81M
    +78.1%
    -$32.97M
    +14.2%
    -$16.57M
    +70.1%
    Strengthening
    MarginsOPM
    -192.6%
    -191.8%
    -123.6%
    -234.3%
    -188.5%
    +2.1%
    -77.7%
    +59.5%
    -121.1%
    +2.0%
    -132.0%
    +43.7%
    Strengthening
    Tax
    -0.2%
    1.0%
    -0.4%
    -2.3%
    0.0%
    +100.0%
    5.9%
    +475.7%
    0.0%
    +100.0%
    0.0%
    +100.0%
    Strengthening
    ReturnsROIC
    2.6%
    1.8%
    2.3%
    3.4%
    2.4%
    -6.8%
    0.4%
    -79.1%
    2.0%
    -14.6%
    1.0%
    -70.8%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY22FY23FY24FY25TTM
    AssetsCash & Equivalents$326.44M$278.60M$250.87M$261.34M$219.11M
    Short-Term Investments
    Total Current Assets$434.98M$336.29M$291.25M$306.33M$261.71M
    Net PP&E$10.26M$16.13M$13.43M$1.30M$1.10M
    Goodwill
    Intangibles
    Total Assets$490.86M$354.78M$321.98M$323.15M$279.38M
    LiabilitiesTotal Current Liabilities$81.94M$67.67M$80.47M$70.16M$86.33M
    Short-Term Debt$0$3.00M$6.18M
    Long-Term Debt
    Long-Term Leases$6.56M$10.18M$8.00M$1.03M$946.0K
    Total Liabilities$411.41M$503.03M$524.62M$508.98M$507.58M
    EquityCommon Stock & APIC$7.31M$7.31M$8.43M$11.08M$11.25M
    Retained Earnings-$1.10B-$1.34B-$1.49B-$1.64B-$1.69B
    Total Equity$79.45M-$148.25M-$202.64M-$185.83M-$228.21M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$138.31M-$118.69M-$123.83M-$141.17M-$102.27M
    Cash from Investing-$687.0K-$3.22M-$867.0K$395.0K$627.0K
    Cash from Financing-$897.0K$73.88M$97.05M$150.94M$56.21M
    SummaryCapital Expenditure-$687.0K-$3.22M-$867.0K-$264.0K-$32.0K
    Free Cash Flow-$139.00M-$121.90M-$124.70M-$141.44M-$102.30M
    FCF Margin-66.2%-175.3%-176.0%-173.8%-128.5%

    Ratios